IL127427A - Radiopharmaceuticals and matrices and their use - Google Patents

Radiopharmaceuticals and matrices and their use

Info

Publication number
IL127427A
IL127427A IL12742797A IL12742797A IL127427A IL 127427 A IL127427 A IL 127427A IL 12742797 A IL12742797 A IL 12742797A IL 12742797 A IL12742797 A IL 12742797A IL 127427 A IL127427 A IL 127427A
Authority
IL
Israel
Prior art keywords
radiopharmaceutical
radiopharmaceutical composition
radioactive
composition according
salt
Prior art date
Application number
IL12742797A
Other languages
English (en)
Hebrew (he)
Other versions
IL127427A0 (en
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/869,460 external-priority patent/US6241962B1/en
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of IL127427A0 publication Critical patent/IL127427A0/xx
Publication of IL127427A publication Critical patent/IL127427A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12742797A 1996-06-24 1997-06-17 Radiopharmaceuticals and matrices and their use IL127427A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66916996A 1996-06-24 1996-06-24
US08/869,460 US6241962B1 (en) 1996-06-24 1997-06-05 Radiopharmaceutical compositions and matrices and uses thereof
PCT/US1997/010585 WO1997049335A1 (en) 1996-06-24 1997-06-17 Novel radiopharmaceutical compositions and matrices and uses thereof

Publications (2)

Publication Number Publication Date
IL127427A0 IL127427A0 (en) 1999-10-28
IL127427A true IL127427A (en) 2002-11-10

Family

ID=27100070

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12742797A IL127427A (en) 1996-06-24 1997-06-17 Radiopharmaceuticals and matrices and their use

Country Status (13)

Country Link
US (1) US6348184B1 (pt)
EP (1) EP0921756A4 (pt)
JP (1) JP2002514159A (pt)
KR (1) KR20000022136A (pt)
AU (1) AU3492797A (pt)
BR (1) BR9710038A (pt)
CA (1) CA2259343C (pt)
CZ (1) CZ401898A3 (pt)
HR (1) HRP970345A2 (pt)
IL (1) IL127427A (pt)
PL (1) PL330820A1 (pt)
TR (1) TR199802686T2 (pt)
WO (1) WO1997049335A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299175B1 (it) * 1998-05-11 2000-02-29 Enea Ente Nuove Tec Composizione contenente radioisotopi immobilizzati su particelle solide, utile in particolare per la brachiterapia clinica in patologie
GB9915714D0 (en) 1999-07-05 1999-09-08 Nycomed Amersham Plc Products and methods
US20040258614A1 (en) * 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
JP5079510B2 (ja) * 2004-09-24 2012-11-21 バイオスフィア メディカル， インコーポレイテッド 放射性同位体を結合し得、任意選択的に金属微粒子を含むミクロスフェア、およびそれらの使用方法
NL2009688C2 (en) * 2012-10-24 2014-04-29 Nucletron Operations Bv A settable radioactive gel, a method of manufacturing a settable radioactive gel, a device for manufacturing a settable radioactive gel.
EP2968165B1 (en) 2013-03-13 2023-09-13 Biosphere Medical, Inc. Compositions and associated methods for radioisotope-binding microparticles
US10363324B2 (en) 2013-11-04 2019-07-30 The South African Nuclear Energy Corporation Limited Pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323055A (en) 1980-04-08 1982-04-06 Minnesota Mining And Manufacturing Company Radioactive iodine seed
US4533541A (en) * 1983-08-25 1985-08-06 The United States Of America As Represented By The United States Department Of Energy Tin-117m-labeled stannic (Sn4+) chelates
US4697575A (en) 1984-11-21 1987-10-06 Henry Ford Hospital Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
US4706652A (en) 1985-12-30 1987-11-17 Henry Ford Hospital Temporary radiation therapy
US4935222A (en) * 1986-06-13 1990-06-19 University Of Cincinnati Procedure for isolating and purifying radioactive ligated rhenium pharmaceuticals and use thereof and kit
US4994013A (en) 1988-07-28 1991-02-19 Best Industries, Inc. Pellet for a radioactive seed
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
US5282781A (en) 1990-10-25 1994-02-01 Omnitron International Inc. Source wire for localized radiation treatment of tumors
US6241962B1 (en) * 1996-06-24 2001-06-05 Dupont Pharmaceuticals Company Radiopharmaceutical compositions and matrices and uses thereof

Also Published As

Publication number Publication date
HRP970345A2 (en) 1998-04-30
CZ401898A3 (cs) 1999-07-14
CA2259343A1 (en) 1997-12-31
WO1997049335A1 (en) 1997-12-31
BR9710038A (pt) 2000-01-11
AU3492797A (en) 1998-01-14
CA2259343C (en) 2002-12-03
KR20000022136A (ko) 2000-04-25
US6348184B1 (en) 2002-02-19
TR199802686T2 (xx) 1999-04-21
JP2002514159A (ja) 2002-05-14
EP0921756A1 (en) 1999-06-16
EP0921756A4 (en) 2003-05-21
IL127427A0 (en) 1999-10-28
PL330820A1 (en) 1999-06-07

Similar Documents

Publication Publication Date Title
RU2199348C2 (ru) Новые радиофармацевтические композиции и матрицы и их использование
CA2660507A1 (en) Targeted nanoparticles for cancer diagnosis and treatment
US6241962B1 (en) Radiopharmaceutical compositions and matrices and uses thereof
Ariel et al. Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes
US6348184B1 (en) Radiopharmaceutical compositions and matrices and uses thereof
WO2019243419A1 (en) Brachygel for treatment of cancer and/or for guidance of surgery
Wang et al. Hepatic artery injection of yttrium-90-lipiodol: biodistribution in rats with hepatoma
WO2009045230A1 (en) Compositions for treatment of tumors by direct administration of a radioisotope
US6685913B1 (en) Lipid soluble radioactive metal chelates for tumor therapy
Yoon et al. Transcatheter Arterial Embolization with 188Rhenium-HDD–labeled Iodized Oil in Rabbit VX2 Liver Tumor
Larson et al. Pharmacologic enhancement of gallium-67 tumor-to-blood ratios for EMT-6 sarcoma (BALB/c mice)
US20120251442A1 (en) Methods for Treatment of Tumors by Direct Administration of a Radioisotope
US6358194B1 (en) Medical use of xenon-133 in radiation therapy of cancer
Wang et al. Intraoperative therapy with liposomal drug delivery: Retention and distribution in human head and neck squamous cell carcinoma xenograft model
AU9742601A (en) Novel radiopharmaceutical compositions and matrices and uses thereof
Jacobstein et al. Uptake of 206Bi citrate in carcinoma of the breast
NZ333556A (en) Radiopharmaceutical compositions comprising radioactive metal salts of pyrophosporic acid derivatives and matrices thereof
DK167907B1 (da) Anvendelse af micellulaere partikler til fremstilling af farmaceutiske praeparater til maalrettet tilfoersel til tumorer i mennesker
MXPA99000100A (en) Novelty radiopharmaceutical compositions and matrices and uses of mis
Simon et al. Scanning bremsstrahlung of yttrium-90 microspheres injected intra-arterially
Junfeng et al. Preparation of [188Re] rhenium sulfide suspension and its biodistribution following intra‐tumor injection in mice
Chiou et al. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer
KR100700418B1 (ko) 방사성물질-키토산 복합체를 함유하는 전립선암 치료용조성물 및 조성물 제조용 키트
KR100501534B1 (ko) 방사성 동위원소 치료를 위한 방사성 레늄주석콜로이드 및 그 제법
RU2781902C1 (ru) Способ лечения аденокарциномы эрлиха методом лучевой терапии

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees